4//SEC Filing
Ryan Charles S. 4
Accession 0001209191-23-048483
CIK 0001662774other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 5:43 PM ET
Size
5.7 KB
Accession
0001209191-23-048483
Insider Transaction Report
Form 4
Ryan Charles S.
President
Transactions
- Award
Employee Stock Option (right to buy)
2023-09-01+545,000→ 545,000 totalExercise: $1.30Exp: 2033-08-31→ Common Stock (545,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest one year after the date of the grant of September 1, 2023 and the remaining shares will vest in equal monthly installments over the following three years thereafter.
Documents
Issuer
Quince Therapeutics, Inc.
CIK 0001662774
Entity typeother
Related Parties
1- filerCIK 0001624830
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 5:43 PM ET
- Size
- 5.7 KB